Paclitaxel Injection, Solution, Concentrate
Product Images NDC 0703-3213

This is a description of a drug called Paclitaxel Injection USP, which comes in a multidose vial containing 30 mg of semi-synthetic source. Dilution is required before intravenous use, and the package insert should be read carefully. Pharmacists are encouraged to dispense this drug with the attached patient information leaflet. The drug is considered a cytotoxic agent and should be handled with gloves at all times. The drug should be stored between 20° to 25°C (68° to 77°F) and protected from light, and the lot number and expiration date can be found on the bottom of the box. Each mL of the drug contains 6 mg of paclitaxel, USP, 527 mg of palyoxyl 35 castor oil, 2 mg of anhydrous citric acid, and 49.7% (v/v) and 39.6% (wiv) of dehydrated alcohol. Dosage and usage directions can be found in the package insert. It was manufactured by Pharmachemie B. in Haarlem, the Netherlands, and is sold under NDC 0703-3213-01 by Teva Pharmaceuticals USA, Inc.*

Semi-Synthetic Source Paclitaxel Injection USP is a Cytotoxic agent available in multidose vial containing 100 mg (6 mg/ml). Dilution is required prior to IV use and gloves should be worn at all times when handling containers. Detailed dosage, directions for use and precautions are provided in the package insert for full prescribing information. It should be stored at a temperature between 20°C (68°F) to 25°C (77°F).*

This appears to be a product description for a medication called Paclitaxel Injection, USP. The medication comes in a 25 ml multidose vial that contains 150 mg of Paclitaxel and should be stored in a controlled room environment until use. The package insert includes directions for dilution prior to IV use and recommends wearing gloves while handling the container. The medication is manufactured by Teva Pharmaceuticals and was produced in North Wales, PA.*

This appears to be a statistical report or chart, showing survival rates in relation to different events and groups. The proportion surviving is not given, but there are columns for the number of events and the hazard ratio as well as a table with numbers at risk. It is not clear what the events or groups represent, as there is no context or explanation provided.*

This text seems to present a graph or a table showing the "Proportion Disease Free" for a given treatment (AC+T) or control group (AC) over a period of time (measured in years). The percentage of patients who were disease-free is given in the table. "Number at Risk" indicates the number of patients in each group, and the numbers 0-4 at the bottom may represent time intervals or stages of the disease. The text does not provide enough context to give more detailed information or interpretation.*

This appears to be a table of survival proportions from a study or experiment. It includes information on the number of individuals at risk, events (such as deaths or other outcomes), and the hazard ratio (the measure of how often the events occur between two groups being compared). It is not possible to determine the context or further details without additional information.*